Effects of paclitaxel and nuclear factor NF-κB inhibitor in thyroid cancer tumors in vivo

Authors

  • V.M. Pushkarev
  • O. I. Kovzun
  • V.V. Pushkarev
  • M.D. Tronko

DOI:

https://doi.org/10.15407/dopovidi2014.05.164

Keywords:

inhibitor, nuclear factor, paclitaxel, thyroid cancer tumors

Abstract

Nuclear factor kappa B (NF-κB) inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) enhances the therapeutic effect of paclitaxel on tumors formed by the xenotransplantation of anaplastic thyroid carcinoma FRO cells. In animals treated with paclitaxel and NF-κB inhibitor, a reduction in the tumor volume was observed, which is significantly different from the effects of each of the compounds in particular. Thus, the combined use of paclitaxel and NF-κB inhibitor is a promising strategy for further preclinical studies for developing the new chemotherapeutic approaches for the anaplastic thyroid cancer treatment.

Downloads

Download data is not yet available.

References

Jordan M. A., Wilson L. Nat. Rev. Canc., 2004, 4: 253–265. https://doi.org/10.1038/nrc1317

Pushkarev V. M., Starenki D. V., Saenko V. A. et al. Endocrinology, 2004, 145, No. 7: 3143–3152. https://doi.org/10.1210/en.2004-0127

Tronko M. D., Pushkarev V. V., Kovzun O. I., Pushkarev V. M. Endokrynologiia, 2013, 18, No. 2: 78-91 (in Ukrainian).

Orlowski R. Z., Baldwin A. S., jr. Trends Mol. Med., 2002, 8, No. 8: 385–389. https://doi.org/10.1016/S1471-4914(02)02375-4

Liptay S., Weber C. K., Ludwig L. et al. Int. J. Cancer., 2003, 105: 735–746. https://doi.org/10.1002/ijc.11081

Karin M. Cell Res., 2008, 18: 334–342. https://doi.org/10.1038/cr.2008.30

Wang H., Cho C. H. Curr. Cancer Drug Targets., 2010, 10, No. 6: 593–599. https://doi.org/10.2174/156800910791859425

Pacifico F., Mauro C., Barone C. et al. J. Biol. Chem., 2004, 279, No. 52: 54610–54619. https://doi.org/10.1074/jbc.M403492200

Pacifico F., Leonardi A. Mol. Cell. Endocrinol., 2010, 321, No. 1: 29–35. https://doi.org/10.1016/j.mce.2009.10.010

Kovzun O. I., Pushkarev V. V. Endokrynologiia, 2005, 10, No. 1: 130–133 (in Ukrainian).

Chen W., Li Z., Bai L., Lin Y. Front. Biosci., 2011, 16: 1172–1185. https://doi.org/10.2741/3782

Luo J. L., Kamata H., Karin M. J. Clin. Invest., 2005, 115, No. 10: 2625–2632. https://doi.org/10.1172/JCI26322

Published

25.02.2025

How to Cite

Pushkarev, V., Kovzun, O. I., Pushkarev, V., & Tronko, M. (2025). Effects of paclitaxel and nuclear factor NF-κB inhibitor in thyroid cancer tumors in vivo . Reports of the National Academy of Sciences of Ukraine, (5), 164–167. https://doi.org/10.15407/dopovidi2014.05.164

Most read articles by the same author(s)

1 2 > >>